G. Saviola Reumatologo

Le mie ultime pubblicazioni

 

Saviola G-Gli steroidi in reumatologia. Focus sul desametasone 2023-pacinimedicina.it

Rosini S, Saviola G, Florian A, Molfetta L. Leptin: Interactions in Bone Metabolism and Pleiotropic Effects Review J. Biol. Regul. Homeost. Agents. 2023.

Rosini S, Rosini S, Saviola G, Molfetta L. Osteocytes: an essential knowledge.EC ORTHOPAEDICS, 2024

Rosini Sergio,,Rosini Stefano, Saviola Gianantonio, Molfetta Luigi. ATP: a new player in CRPS type 1, Minerva Medica,2024

Rosini Sergio,,Rosini Stefano, Saviola Gianantonio, Molfetta Luigi Osteonecrosis of the Jaw: Not All Bisphosphonates are the Same, EC Dental Science, 2023

Rosini S, Rosini S, Saviola G, Molfetta L. Clodronate: the influence on ATP purinergic signaling, CRR,  2025

Rosini S, Rosini S, Saviola G, Molfetta L. Netrin-1: a complex new player in many pathologies. EC Orthopedics, 2025

Saviola G, Rosini S, Molfetta L, Dalle Carbonare L, Malavolta n, Mazzei MA, Muratore M, Frediani B. Bone Marrow Edema in osteoarthritis and bone trauma. Diagnose and Treatment, Clin Ter ,2025

Molfetta L, Rosini S, Saviola G. Dalle Carbonare L, Muratore M, Mazzei MA, Malavolta N, Frediani B.-Physiopathology and pharmacological protectionof periprosthetic bone- Clin Ter 2025.

Saviola G,, Molfetta L, Rosini S, Molfetta L,. Dalle Carbonare L,Malavolta N, Di Meglio N, Mazzei MA, Muratore M,  Frediani B.-The warm phase of CRPS Type-1:Is it time to review the Budapest Criteria?- Diagnostics, 2025.

Rosini S, Saviola G, Molfetta L. Clodronate and Neridronate cornerstones os osteometabolic therapy- Clin Ter 2026

Saviola G, Abdi-Ali l., Zambarda C, Imperadori M, Negro L, Nicolosi A, Cosmi F. – Can BES TEST help  in assessing the risk of fragility fractures in patients with normal or osteopenic DEXA  T-score? Revista de Osteoporosis y Metabolismo Mineral, 2026 in press.